Article info
PDFLetter
The influence of the pharmaceutical industry on the off-label use of its medicines
Citation
The influence of the pharmaceutical industry on the off-label use of its medicines
Publication history
- First published August 1, 2002.
Online issue publication
August 01, 2002
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by the Journal of Medical Ethics
Other content recommended for you
- Unlicensed and off label drug use in neonates
- Emerging role of thalidomide in the treatment of gastrointestinal bleeding
- Intravitreal thalidomide reduces experimental preretinal neovascularisation without induction of retinal toxicity
- Frances Kathleen Oldham Kelsey
- Absence of significant adverse events following thalidomide administration in bitches diagnosed with mammary gland carcinomas
- Survey of unlicensed and off label drug use in paediatric wards in European countries
- Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
- Thalidomide and its derivatives: emerging from the wilderness
- Licensing of medicines
- Hair repigmentation associated with thalidomide use for the treatment of multiple myeloma